APA (7th ed.) Citation

Livingstone, D. E. W., Barat, P., Di Rollo, E. M., Rees, G. A., Weldin, B. A., Rog-Zielinska, E. A., . . . Andrew, R. (2015). 5α-Reductase Type 1 Deficiency or Inhibition Predisposes to Insulin Resistance, Hepatic Steatosis, and Liver Fibrosis in Rodents. Diabetes, 64(2), 447. https://doi.org/10.2337/db14-0249

Chicago Style (17th ed.) Citation

Livingstone, Dawn E. W., Pascal Barat, Emma M. Di Rollo, Georgina A. Rees, Benjamin A. Weldin, Eva A. Rog-Zielinska, David P. MacFarlane, Brian R. Walker, and Ruth Andrew. "5α-Reductase Type 1 Deficiency or Inhibition Predisposes to Insulin Resistance, Hepatic Steatosis, and Liver Fibrosis in Rodents." Diabetes 64, no. 2 (2015): 447. https://doi.org/10.2337/db14-0249.

MLA (9th ed.) Citation

Livingstone, Dawn E. W., et al. "5α-Reductase Type 1 Deficiency or Inhibition Predisposes to Insulin Resistance, Hepatic Steatosis, and Liver Fibrosis in Rodents." Diabetes, vol. 64, no. 2, 2015, p. 447, https://doi.org/10.2337/db14-0249.